# FDA Inspection 1187499 - OneBlood Inc. - October 26, 2022

Source: https://www.keypedia.com/records/fda_inspections/oneblood-inc/b57e5b21-a677-4de6-9c34-e3fc2bdf1e32
Source feed: FDA_Inspections

> FDA Inspection 1187499 for OneBlood Inc. on October 26, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1187499
- Company Name: OneBlood Inc.
- Inspection Date: 2022-10-26
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1187499 - 2022-10-26](https://www.keypedia.com/records/fda_inspections/oneblood-inc/d576fe98-2e6a-4436-9e27-ba5bbe695c7b)

Company: https://www.keypedia.com/companies/oneblood-inc/5b144cd3-3e56-4d46-a38c-8d854b06d080

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d